Cargando…

Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy

INTRODUCTION: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). METHODS: Study group included 52 controls (46% male, age: 54.5±12.4) and 101...

Descripción completa

Detalles Bibliográficos
Autores principales: Akpınar, Kadriye, Aslan, Diler, Fenkçi, Semin Melahat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428651/
https://www.ncbi.nlm.nih.gov/pubmed/33599678
http://dx.doi.org/10.1590/2175-8239-JBN-2020-0145
_version_ 1783750418711445504
author Akpınar, Kadriye
Aslan, Diler
Fenkçi, Semin Melahat
author_facet Akpınar, Kadriye
Aslan, Diler
Fenkçi, Semin Melahat
author_sort Akpınar, Kadriye
collection PubMed
description INTRODUCTION: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). METHODS: Study group included 52 controls (46% male, age: 54.5±12.4) and 101 diabetic patients (46.5% male, age: 58.2±11). The diabetics were divided into three subgroups according to 24-hour urine albumin: normal to mildly increased (A1) (n=51), moderately increased (A2) (n=25), severely increased (A3) (n=25) albuminuria. Creatinine clearance (CrCl) was determined. Correlations between CrCl and eGFRs estimated according to the CKD-EPI, MDRD, and Cockcroft-Gault (CG) formulas, and ROC curves were evaluated. Data were analyzed using SPSS 22.0. RESULTS: Only CKD-EPI-cys eGFR was significantly lower in the A1 group than the controls (p=0.021). All GFRs were lower in the A3 group than the control (CKD-EPI-cr, MDRD, CKD-EPI-cys, CKD-EPI-cr-cys: p=0.0001, CG and CrCl: p=0.001) and A1 (for all GFRs p=0.0001) groups. CKD-EPI-cr (p=0.004), MDRD (p=0.01), CG (p=0.037), CKD-EPI-cys (p=0.033), and CKD-EPI-cr-cys (p=0.016) eGFRs in the A2 group were significantly different from the A1 group. All eGFRs showed a moderate correlation with CrCl in the A1group (CKD-EPI-cr and CKD-EPI-cr-cys: r=0.49, p=0.0001, MDRD: r=0.44, p=0.001, CG r=0.48, p=0.0001: CKD-EPI-cys r=0.40, p=0.004). The area under the CKD-EPI-cys ROC curve was the highest and found to be 0.847 (95%CI 0.763-0.931, p=0.0001). CONCLUSIONS: Our results showed that the CKD-EPI-cys eGFR can be useful in detecting the early stage of DN and more predictive than the others for prediction of DN.
format Online
Article
Text
id pubmed-8428651
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Nefrologia
record_format MEDLINE/PubMed
spelling pubmed-84286512021-09-16 Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy Akpınar, Kadriye Aslan, Diler Fenkçi, Semin Melahat J Bras Nefrol Original Article INTRODUCTION: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). METHODS: Study group included 52 controls (46% male, age: 54.5±12.4) and 101 diabetic patients (46.5% male, age: 58.2±11). The diabetics were divided into three subgroups according to 24-hour urine albumin: normal to mildly increased (A1) (n=51), moderately increased (A2) (n=25), severely increased (A3) (n=25) albuminuria. Creatinine clearance (CrCl) was determined. Correlations between CrCl and eGFRs estimated according to the CKD-EPI, MDRD, and Cockcroft-Gault (CG) formulas, and ROC curves were evaluated. Data were analyzed using SPSS 22.0. RESULTS: Only CKD-EPI-cys eGFR was significantly lower in the A1 group than the controls (p=0.021). All GFRs were lower in the A3 group than the control (CKD-EPI-cr, MDRD, CKD-EPI-cys, CKD-EPI-cr-cys: p=0.0001, CG and CrCl: p=0.001) and A1 (for all GFRs p=0.0001) groups. CKD-EPI-cr (p=0.004), MDRD (p=0.01), CG (p=0.037), CKD-EPI-cys (p=0.033), and CKD-EPI-cr-cys (p=0.016) eGFRs in the A2 group were significantly different from the A1 group. All eGFRs showed a moderate correlation with CrCl in the A1group (CKD-EPI-cr and CKD-EPI-cr-cys: r=0.49, p=0.0001, MDRD: r=0.44, p=0.001, CG r=0.48, p=0.0001: CKD-EPI-cys r=0.40, p=0.004). The area under the CKD-EPI-cys ROC curve was the highest and found to be 0.847 (95%CI 0.763-0.931, p=0.0001). CONCLUSIONS: Our results showed that the CKD-EPI-cys eGFR can be useful in detecting the early stage of DN and more predictive than the others for prediction of DN. Sociedade Brasileira de Nefrologia 2021-02-12 2021 /pmc/articles/PMC8428651/ /pubmed/33599678 http://dx.doi.org/10.1590/2175-8239-JBN-2020-0145 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Akpınar, Kadriye
Aslan, Diler
Fenkçi, Semin Melahat
Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
title Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
title_full Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
title_fullStr Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
title_full_unstemmed Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
title_short Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy
title_sort assessment of estimated glomerular filtration rate based on cystatin c in diabetic nephropathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428651/
https://www.ncbi.nlm.nih.gov/pubmed/33599678
http://dx.doi.org/10.1590/2175-8239-JBN-2020-0145
work_keys_str_mv AT akpınarkadriye assessmentofestimatedglomerularfiltrationratebasedoncystatincindiabeticnephropathy
AT aslandiler assessmentofestimatedglomerularfiltrationratebasedoncystatincindiabeticnephropathy
AT fenkciseminmelahat assessmentofestimatedglomerularfiltrationratebasedoncystatincindiabeticnephropathy